23. Clinical benefit table: Hyalgan versus NSAID. Continuous outcome measures.

Study	Time	Treatment	Outcome (scale)	N of Pts	Baseline Mean	End of Study Mean	Absolute Benefit	Relative Difference
Altman 1998	1‐4 wk	E: Hyalgan	Pain after 50 foot walk (0‐100 mm VAS)	163	54	25	0	0
		C: Naproxen		162	54	25
Altman 1998	5‐13 wk	E: Hyalgan	Pain after 50 foot walk (0‐100 mm VAS)	115	54	23	2 (W)	3.7% (W)
		C: Naproxen		125	54	21
Altman 1998	14‐26 wk	E: Hyalgan	Pain after 50 foot walk (0‐100 mm VAS)	105	54	18	‐3 (I)	‐5.6% (I)
		C: Naproxen		111	54	21